HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ascending thoracic aortic aneurysm wall stress analysis using patient-specific finite element modeling of in vivo magnetic resonance imaging.

AbstractOBJECTIVES:
Rupture/dissection of ascending thoracic aortic aneurysms (aTAAs) carries high mortality and occurs in many patients who did not meet size criteria for elective surgery. Elevated wall stress may better predict adverse events, but cannot be directly measured in vivo, rather determined from finite element (FE) simulations. Current computational models make assumptions that limit accuracy, most commonly using in vivo imaging geometry to represent zero-pressure state. Accurate patient-specific wall stress requires models with zero-pressure three-dimensional geometry, material properties, wall thickness and residual stress. We hypothesized that wall stress calculated from in vivo imaging geometry at systemic pressure underestimates that using zero-pressure geometry. We developed a novel method to derive zero-pressure geometry from in vivo imaging at systemic pressure. The purpose of this study was to develop the first patient-specific aTAA models using magnetic resonance imaging (MRI) to assess material properties and zero-pressure geometry. Wall stress results from FE models using systemic pressure were compared with those from models using zero-pressure correction.
METHODS:
Patients with aTAAs <5 cm underwent ECG-gated computed tomography angiography (CTA) and displacement encoding with stimulated echo (DENSE)-MRI. CTA lumen geometry was used to create surface contour meshes of aTAA geometry. DENSE-MRI measured cyclic aortic wall strain from which wall material property was derived. Zero- and systemic pressure geometries were created. Simulations were loaded to systemic pressure using the ABAQUS FE software. Wall stress analyses were compared between zero-pressure-corrected and systemic pressure geometry FE models.
RESULTS:
Peak first principal wall stress (primarily aligned in the circumferential direction) at systolic pressure for the zero-pressure correction models was 430.62 ± 69.69 kPa, whereas that without zero-pressure correction was 312.55 ± 39.65 kPa (P = 0.004). Peak second principal wall stress (primarily aligned in the longitudinal direction) at systolic pressure for the zero-pressure correction models was 200.77 ± 43.13 kPa, whereas that without zero-stress correction was 156.25 ± 25.55 kPa (P = 0.02).
CONCLUSIONS:
Previous FE aTAA models from in vivo CT and MRI have not accounted for zero-pressure geometry or patient-specific material property. We demonstrated that zero-pressure correction significantly impacts wall stress results. Future computational models that use wall stress to predict aTAA adverse events must take into account zero-pressure geometry and patient material property for accurate wall stress determination.
AuthorsKapil Krishnan, Liang Ge, Henrik Haraldsson, Michael D Hope, David A Saloner, Julius M Guccione, Elaine E Tseng
JournalInteractive cardiovascular and thoracic surgery (Interact Cardiovasc Thorac Surg) Vol. 21 Issue 4 Pg. 471-80 (Oct 2015) ISSN: 1569-9285 [Electronic] England
PMID26180089 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightPublished by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Topics
  • Angiography
  • Aorta (physiopathology)
  • Aortic Aneurysm, Thoracic (diagnosis, physiopathology)
  • Biomechanical Phenomena
  • Computer Simulation
  • Finite Element Analysis
  • Humans
  • Imaging, Three-Dimensional
  • Magnetic Resonance Imaging
  • Models, Cardiovascular
  • Pressure
  • Stress, Mechanical
  • Tomography, X-Ray Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: